Kevonna Hayes

Privia Health and Javara Selected to Participate in AstraZeneca Phase III Clinical Trial for COVID-19 Vaccine AZD1222

By Kevonna Hayes / November 9, 2020

ARLINGTON, VA – (November 9, 2020) – Privia Health (“Privia”), in partnership with Javara, announced our participation in a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE…

Read More

Wake Forest Baptist Health and Javara Begin Recruiting Healthy Adults for COVID-19 Vaccine Clinical Trial

By Kevonna Hayes / August 7, 2020

WINSTON-SALEM, N.C. – Aug. 7, 2020 – Wake Forest Baptist Health, in partnership with Javara, announced today they have begun recruiting healthy adults for a Phase 3 clinical research study…

Read More

Javara Expands Its Footprint to Maryland, Virginia and Washington, DC, Areas in Partnership with Privia Medical Group

By Kevonna Hayes / July 15, 2020

Javara is expanding our reach and ability to bring more patients to clinical trials in partnership with Privia Medical Group and their physicians in Maryland, Virginia and the Washington, DC…

Read More

What’s a ‘Myocardial Infarction’?

By Kevonna Hayes / August 28, 2019

Closing the gap in clinical research participation through addressing health literacy Do you know what myocardial infarction means? In more simple terms, it’s a heart attack. Myocardial infarction and heart…

Read More

Engaging the Next Generation of Clinical Trial Leaders

By Kevonna Hayes / August 5, 2019

As the clinical trial industry continues to evolve and grow, so must clinical research professionals — now and in the future. At Javara, we recognize the importance of building the…

Read More